These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30919036)

  • 21. The effectiveness of inositol and metformin on infertile polycystic ovary syndrome women with resistant to letrozole.
    Pourghasem S; Bazarganipour F; Taghavi SA; Kutenaee MA
    Arch Gynecol Obstet; 2019 Apr; 299(4):1193-1199. PubMed ID: 30847561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of myo-inositol/di-chiro-inositol on markers of ovarian reserve in women with PCOS undergoing IVF/ICSI: A systematic review and meta-analysis.
    Bhide P; Pundir J; Gudi A; Shah A; Homburg R; Acharya G
    Acta Obstet Gynecol Scand; 2019 Oct; 98(10):1235-1244. PubMed ID: 30993683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breakthroughs in the Use of Inositols for Assisted Reproductive Treatment (ART).
    Facchinetti F; Espinola MSB; Dewailly D; Ozay AC; Prapas N; Vazquez-Levin M; Wdowiak A; Unfer V;
    Trends Endocrinol Metab; 2020 Aug; 31(8):570-579. PubMed ID: 32418772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of FT500 Plus(®) on ovarian stimulation in PCOS women.
    Alviggi C; Cariati F; Conforti A; De Rosa P; Vallone R; Strina I; Pivonello R; De Placido G
    Reprod Toxicol; 2016 Jan; 59():40-4. PubMed ID: 26545973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial.
    Costantino D; Minozzi G; Minozzi E; Guaraldi C
    Eur Rev Med Pharmacol Sci; 2009; 13(2):105-10. PubMed ID: 19499845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial.
    Colazingari S; Treglia M; Najjar R; Bevilacqua A
    Arch Gynecol Obstet; 2013 Dec; 288(6):1405-11. PubMed ID: 23708322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial.
    Ciotta L; Stracquadanio M; Pagano I; Carbonaro A; Palumbo M; Gulino F
    Eur Rev Med Pharmacol Sci; 2011 May; 15(5):509-14. PubMed ID: 21744744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of myo-inositol supplementation on ICSI outcomes among poor ovarian responder patients: A randomized controlled trial.
    Nazari L; Salehpour S; Hosseini S; Saharkhiz N; Azizi E; Hashemi T; Ghodssi-Ghassemabadi R
    J Gynecol Obstet Hum Reprod; 2020 May; 49(5):101698. PubMed ID: 32018040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial.
    Mendoza N; Diaz-Ropero MP; Aragon M; Maldonado V; Llaneza P; Lorente J; Mendoza-Tesarik R; Maldonado-Lobon J; Olivares M; Fonolla J
    Gynecol Endocrinol; 2019 Aug; 35(8):695-700. PubMed ID: 30880505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
    Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of follicular antimullerian hormone levels of non-obese, non-hyperandrogenemic polycystic ovary syndrome patients on assisted reproduction outcome.
    Yilmaz N; Uygur D; Dogan M; Ozgu E; Salman B; Mollamahmutoglu L
    Gynecol Endocrinol; 2012 Mar; 28(3):162-5. PubMed ID: 22103791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials.
    Mendoza N; Pérez L; Simoncini T; Genazzani A
    Reprod Biomed Online; 2017 Nov; 35(5):529-535. PubMed ID: 28756130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction.
    Papaleo E; Unfer V; Baillargeon JP; De Santis L; Fusi F; Brigante C; Marelli G; Cino I; Redaelli A; Ferrari A
    Gynecol Endocrinol; 2007 Dec; 23(12):700-3. PubMed ID: 17952759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Astaxanthin treatment decreases pro-inflammatory cytokines and improves reproductive outcomes in patients with polycystic ovary syndrome undergoing assisted reproductive technology: A randomized clinical trial.
    Fereidouni F; Kashani L; Amidi F; Khodarahmian M; Zhaeentan S; Ardehjani NA; Rastegar T
    Inflammopharmacology; 2024 Aug; 32(4):2337-2347. PubMed ID: 38916710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome.
    Mashiach R; Amit A; Hasson J; Amzalzg S; Almog B; Ben-Yosef D; Lessing JB; Limor R; Azem F
    Fertil Steril; 2010 May; 93(7):2299-302. PubMed ID: 19261276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
    Unfer V; Carlomagno G; Rizzo P; Raffone E; Roseff S
    Eur Rev Med Pharmacol Sci; 2011 Apr; 15(4):452-7. PubMed ID: 21608442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the immature human oocytes from unstimulated cycles in polycystic ovary syndrome patients using a novel scoring system.
    Liu S; Jiang JJ; Feng HL; Ma SY; Li M; Li Y
    Fertil Steril; 2010 May; 93(7):2202-9. PubMed ID: 19249763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of different insulin-sensitizing agents on treatment outcomes in patients with polycystic ovary syndrome who underwent in-vitro fertilization: A retrospective, record-based, comparative study.
    Yaylalı A; Bakacak M; Bakacak Z
    J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):102006. PubMed ID: 33242676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myo-Inositol's Role in Assisted Reproductive Technology: Evidence for Improving the Quality of Oocytes and Embryos in Patients With Polycystic Ovary Syndrome.
    Gupta D; Khan S; Islam M; Malik BH; Rutkofsky IH
    Cureus; 2020 May; 12(5):e8079. PubMed ID: 32542134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.